Paper Details

  1. Home
  2. Paper Details

Treatment of HIV-related fatigue with armodafinil: a placebo-controlled randomized trial.

Author: McElhineyMartin C, RabkinJudith G, RabkinRichard

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study found that armodafinil was effective and well tolerated in treating fatigue in HIV+ patients, with a 75% response rate compared to 26% for placebo. Most patients reported substantially improved energy and mood.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To evaluate the efficacy and safety of armodafinil in the treatment of fatigue in HIV+ patients, and to assess its effect on depressive symptoms and behavior once fatigue remitted. METHOD: HIV+ patients with clinically significant fatigue were treated in a placebo-controlled randomized d...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/21777715

データ提供：米国国立医学図書館（NLM）

Finding Relief in the Desert of HIV-Related Fatigue

Living with HIV can be a challenging journey, often accompanied by debilitating fatigue. This research focuses on the potential of armodafinil, a wakefulness-promoting medication, in the treatment of fatigue in HIV-positive individuals. The researchers, like intrepid explorers searching for a cure, conducted a randomized controlled trial to determine if armodafinil could offer relief from this common and often debilitating symptom.

Armodafinil: A Beacon of Hope in the Desert of HIV Fatigue

The study results provide a beacon of hope in the desert of HIV-related fatigue. The researchers found that armodafinil was effective and well-tolerated in treating fatigue in HIV-positive patients. The study demonstrated a significant improvement in energy levels and a reduction in depressive symptoms among those who received armodafinil, offering a potential solution for a common and debilitating challenge faced by many living with HIV.

A Journey of Empowerment and Improved Quality of Life

This research underscores the importance of addressing the physical and mental well-being of individuals living with HIV. It's like finding a refreshing oasis in the desert of chronic illness, offering a potential path to improved quality of life and enhanced coping mechanisms. The findings highlight the importance of continued research and innovation in the search for more effective and well-tolerated treatments for HIV-related fatigue, paving the way for a more empowered and fulfilling journey for individuals living with this complex condition.

Dr. Camel's Conclusion

This research offers a valuable resource for those living with HIV and experiencing fatigue. It's like finding a well in the desert, providing much-needed relief from a common and debilitating symptom. The study underscores the importance of addressing the multifaceted challenges of HIV, reminding us that even in the face of difficult medical conditions, hope and progress are possible. The findings offer a glimmer of hope, suggesting that with continued research and innovation, we can create a more fertile oasis for those navigating the landscape of HIV-related health challenges.

Date :
  1. Date Completed 2011-12-13
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

21777715

DOI: Digital Object Identifier

NIHMS274919

Related Literature

Article Analysis
・Side Effects of armodafinil
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.